Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | P-MUC1C-ALLO1 CAR-T cells |
Synonyms | |
Therapy Description |
P-MUC1C-ALLO1 CAR-T are allogeneic T-cells engineered to target MUC1C, with potential antitumor activity (Journal for ImmunoTherapy of Cancer 2020;8, Issue Suppl 3). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
P-MUC1C-ALLO1 CAR-T cells | P-MUC1C-ALLO1 CAR-T are allogeneic T-cells engineered to target MUC1C, with potential antitumor activity (Journal for ImmunoTherapy of Cancer 2020;8, Issue Suppl 3). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|